Protocol No.: IPM3002; An Open-Label, Adaptive, Randomized Study of Palifosfamide in Combination w/Carboplatin and Etoposide (PaCE) Chemotherapy Versus Carboplatin and Etoposide (CE) Alone in Patients w/Previouly Untreated, Extensive-Stage Small Cell Lu